PRESS STATEMENTS11.10.2020 Pfizer Statement on Geodon (ziprasidone) Trial Closure in the United States10.29.2020 New Report Identifies Need for More Effective Policy Responses and Investment to Prevent Strokes in Europe10.14.2020 Pfizer and BioNTech Announce New England Journal of Medicine Publication of Phase 1 Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-1909.30.2020 BioNTech and Pfizer Announce Nature Publication of German Phase 1/2 Study Data from mRNA-based Vaccine Candidate BNT162b1 Against SARS-CoV-208.17.2020 Pfizer Statement on Lyrica (Pregabalin) Patent Infringement in Japan08.12.2020 Pfizer and BioNTech Announce Publication of Peer-Reviewed Data from Ongoing Phase 1/2 study of mRNA-based Vaccine Candidate, BNT162b1, Against SARS-CoV-2 in Nature08.06.2020 Pfizer signs on to The Hispanic Promise further strengthening its ties and commitment to Hispanics in the workplace08.05.2020 The Bristol-Myers Squibb-Pfizer Alliance is pleased with the U.S. District Court decision to uphold both the composition of matter (COM) patent (US 6,967,208) and formulation patent (US 9,326,945) covering Eliquis®.07.22.2020 Pfizer Shares Pre-Clinical Data Updates on COVID-19 Antiviral Research Program06.29.2020 Pfizer Statement on Facebook Advertising Boycott06.23.2020 NEW DATA ON THE BURDEN OF EMERGING S. PNEUMONIAE SEROTYPES PUBLISHED IN ISPPD 2020 ONLINE DIGITAL LIBRARY06.16.2020 Merck and Pfizer’s SGLT2 Inhibitor STEGLATROTM (ertugliflozin) Meets Primary Endpoint in VERTIS CV Trial for Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease05.28.2020 Corning and Pfizer Announce Supply Agreement for Corning Valor® Glass Packaging05.01.2020 Pfizer Receives Positive CHMP Opinion for DAURISMO® (glasdegib) for Certain Adult Patients with Newly Diagnosed or Secondary Acute Myeloid Leukemia (AML)03.02.2020 Pfizer Provides Comment on COVID-19 White House Meeting01.23.2020 Pfizer Brings Three New Biosimilars to U.S. Patients at Substantial Discounts11.15.2019 Pfizer Announces CHMP Opinion for XELJANZ® (tofacitinib) in the European Union Related to Ongoing Review of the Product10.18.2019 Pfizer Statement on Vincristine Sulfate Injection, USP Supply in the United States10.17.2019 Pfizer Statement on Results of Pay Equity Study and Opportunity Parity Among Colleagues Worldwide09.17.2019 TrialSpark and Pfizer collaborating to improve speed and access to clinical trialsPaginationFirst page« FirstPrevious page‹ Previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7Next pageNext ›Last pageLast »Press Release ArchivePress StatementsPodcastsThe Antigen PodcastThe Antigen Podcast Season 1The Antigen Podcast Episode 1: Vaccines 101The Antigen Podcast Episode 2: The History of VaccinesThe Antigen Podcast Episode 3: Global Perspectives, Barriers & SolutionsThe Antigen Podcast Episode 4: Vaccine Hesitancy Part 1The Antigen Podcast Episode 5: Vaccine Hesitancy Part 2The Antigen Podcast Episode 6: Vaccine Politics, Policy & AdvocacyThe Antigen Podcast Episode 7: Innovations in the Vaccine LandscapeThe Antigen Podcast Episode 8: What's Next?The Antigen Podcast Season 2The Antigen Podcast Episode 1: #COVID19 Looking Back to Look ForwardThe Antigen Podcast Episode 2: #COVID19 What Do We Do in the Meantime?The Antigen Podcast Episode 3: #COVID19 The Quest for a VaccineThe Antigen Podcast Episode 4: #COVID19 Teamwork Makes the Dream WorkGet Science PodcastDiverse Perspectives Podcastmenopause: unmutedHemcastContact Media RelationsPress Kits & DownloadsCompany Press KitPfizer Oncology Press KitPSA NarrativeRA NarRAtiveRare Disease Gene Therapy Press KitATTR-Amyloidosis Press KitUC NarrativeEczema Inside Out Press KitOnline Pfizer Press KitCompany Press KitView the Pfizer Company Press KitPress StatementsView Pfizer's latest press statements Related ArticlesYour HealthIn His Shoes (or Hiking Boots): William’s epic solo adventure to…Our PurposeMichigan is Ready for CuresYour HealthUnderstanding Healthcare Disparities in Colorectal CancerYour HealthKnow the Mutational Status of Your Cancer: Biomarker Testing in…Your HealthPfizer's New C. difficile Awareness Initiative ExplainedYour HealthAlbert Bourla Reflects on the One Year Anniversary of the COVID-…Our PeopleGetting to Know Pfizer’s New Chief Medical Officer Aida HabtezionOur PurposeSome older people living with cancer aim for remission but lack…Our ProductsAlbert Bourla On Ensuring Equitable Access to COVID-19 VaccinesOur PurposeImproving Access to Cures Through InnovationYour HealthLet’s Talk Osteoarthritis Pain: A Picture of Daily LifeOur ScienceThe Facts About Pfizer and BioNTech’s COVID-19 VaccineOur PeopleAn Early Passion for Science and Public Health Inspires Adriana’…Our PeopleSandy Focuses on Diversity in Our Clinical TrialsOur People“The Ice Man” - The Pfizer Colleague & Dad Who Keeps Our…Our ProductsDistributing Our COVID-19 Vaccine to the WorldOur PurposeThe Value of Vaccines in Disease Prevention: A Global PerspectiveOur PurposeThe Value of Vaccines in Disease Prevention in Latin AmericaYour HealthViral vs. Bacterial Pneumonia: Understanding the DifferenceOur ScienceNew Discoveries in Metastatic Breast Cancer Can’t Wait: How…Our PurposeAdvancing Health Equity & Social Justice Through Community…ShowHide
